There are some good ideas being shared about exit strategy, and those plans are hopefully perfect for those who made them.
There are lots of factors that helped me come up with my plan. But the basic plot is: don't sell too much too soon, cut out of enough to enjoy the gains but not so much that it significantly diminishes my position, and hold enough that if Doc does give a dividend the monthly payout would provide generational wealth. There are also my personal finances to consider. I'm willing to give up a small amount of shares at a lower price so I can pay my debts and have some spending money. I've made my plans with preservation of my core position a top priority.
I started buying at .0008, so I am comfortable enough with my overall position to let 100k shares go at .50. If it blasts right by and gets to multiple dollars quickly, the 100k I sold makes no difference. But if it hits .50 and goes below it for a long time I would be kicking myself for not selling a little bit when I had the chance....and be broke for however long it takes for it to go back up.
But, if we get the gap up rather than the trade up, my .50 limit price won't matter anyway because the order will hit the higher bids.
I appreciate the insight and advice on the board about exit strategy. As a whole it helps me to plan my own exit strategy.
So now the entire world knows that I have 100k up at .50. Come 'n get 'em!!!!
4
Univec Conglomerate Inc (UNVC) Stock Research Links
Arch Painting's Commitment to Community Support Arch Painting, a prominent entity in paint contracting services, is taking significant steps to support community initiatives. Recently, the company made headlines by becoming a Gold Sponsor of the Mobility Awareness Resource Community (M.A.R.C.) Network during a high-profile football event. The sponsorship highlights Arch...
Radioligand Therapy Market Growth and Future Outlook The global Radioligand Therapy (RLT) market is witnessing promising growth, with expectations to reach a valuation of USD 10.91 billion by the early 2030s, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2025 onward. This significant progression can be attributed to the increasing number of approvals and...
Introduction to Boston Scientific's 2024 Financial Triumph Boston Scientific Corporation (NYSE: BSX) has announced impressive results for the fourth quarter and the entire year of 2024. The figures indicate robust growth in net sales and earnings, underscoring the company's strong position in the medical technology sector. During the fourth quarter, net sales reached a...
Key Technology Stocks Exhibiting Momentum The information technology sector continues to capture the attention of investors, particularly those who prioritize momentum as a vital part of their trading strategies. In the rapidly evolving landscape of tech stocks, three companies have recently emerged as noteworthy players due to significant momentum indicators that may...
Autoliv Reports Strong Third-Quarter Results On a recently mixed trading day for U.S. stocks, significant gains were noted with the Nasdaq Composite surging approximately 100 points. Among the noteworthy performers, shares of Autoliv, Inc. exhibited an impressive increase following the company’s announcement concerning its third-quarter financial performance. Key...